Eric I. Richman

CEO at Gain Therapeutics
On the record
Represented by:
Bio

Eric I. Richman is the CEO of Gain Therapeutics. He began his career in venture capital at HealthCare Ventures and most recently was venture partner at Brace Pharma Capital, a life science venture capital firm. He also serves as an advisor to Broad Oak Capital, a life science private equity firm and as a Venture Partner at Allele Capital.

Mr. Richman has also previously served as chief executive officer of Tyrogenex and PharmAthene, subsequently acquired by Altimmune. Prior to PharmAthene, Mr. Richman held various commercial and strategic positions at MedImmune over a 12-year period from its inception. He has previously served as a director of Adma Biologics, Zyversa Therapeutics, and LEV Pharma, which was acquired by Viropharma, among others private and public companies.

Employment
Sign up to view all